Kelly Ivory

Kelly Ivory serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions within a federal agency focused on pharmaceutical and health-related missions. She ensures compliance with federal acquisition regulations while executing competitive and transparent contracting processes. Her portfolio centers on the development, manufacturing, and distribution of pharmaceutical preparations, requiring deep technical understanding of cGMP standards, supply chain integrity, and regulatory submissions. Ivory works closely with program offices to translate mission needs into solicitation requirements, conducts market research, and negotiates contract terms to safeguard public interest and ensure timely delivery of critical medical products. While specific contractor names are not disclosed in available records, Ivory consistently engages with a diverse pool of manufacturers and suppliers specializing in pharmaceutical preparation, including both established industry players and emerging small businesses. Her contracting patterns reflect a preference for collaborative, performance-based partnerships that emphasize quality control, regulatory adherence, and supply chain resilience. She actively fosters long-term vendor relationships grounded in transparency, accountability, and compliance with federal procurement standards. Ivory demonstrates an unwavering commitment to small business participation, with 100% of her acquisitions structured as total small business set-asides under FAR 19.5. This reflects a strategic emphasis on expanding economic opportunity for small manufacturers and ensuring robust competition within the pharmaceutical supply base. Her socioeconomic contracting patterns prioritize firms capable of meeting stringent FDA and manufacturing requirements, creating pathways for qualified small businesses to support national health objectives. Her primary technical focus is on NAICS 325412—Pharmaceutical Preparation Manufacturing—encompassing the procurement of sterile injectables, oral solid dosages, and other finished drug products. She possesses specialized expertise in the regulatory and technical nuances of pharmaceutical production, including formulation development, batch validation, and cold chain logistics, making her a key liaison between procurement policy and pharmaceutical science.